Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSIF.L Regulatory News (SSIF)

  • There is currently no data for SSIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

25 Sep 2015 16:49

RNS Number : 2932A
GLI Alternative Finance PLC
25 September 2015
 



 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

GLI Alternative Finance Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

x

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Morgan Stanley

(Institutional Securities Group and Global Wealth Management)

4. Full name of shareholder(s)  (if different from 3.):iv

Morgan Stanley & Co. International plc

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

23/09/2015

6. Date on which issuer notified:

25/09/2015

7. Threshold(s) that is/are crossed orreached: vi, vii

3%,4%,5%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

 

GB00BYMK5S87

 

Below 3%

 

 

Below 3%

 

3,000,000

3,000,000

 

 

5.69%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,000,000

5.69%

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Morgan Stanley & Co. International plc, 25 Cabot Square, Canary Wharf, London E14 4QA is a direct holder of  3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley Investments (UK)

 

Morgan Stanley Investments (UK), 20 Bank Street, Canary Wharf, London E14 4AD is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley UK Group

 

Morgan Stanley UK Group, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley Group (Europe)

 

Morgan Stanley Group (Europe), 20 Bank Street, Canary Wharf, London E14 4AD is an indirect holder 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley International Limited

 

Morgan Stanley International Limited, 25 Cabot Square, Canary Wharf, London E14 4QA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley International Holdings Inc.

 

Morgan Stanley International Holdings Inc, c/o The Corporation Trust Company, Corporation Trust Centre, 1209 Orange Street, Wilmington, Delaware DE19801, USA is an indirect holder of 3,000,000 voting rights (5.69%) and is a subsidiary of Morgan Stanley.

 

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will ceaseto hold:

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

13. Additional information:

 

 

14. Contact name:

Craig Horsley

15. Contact telephone number:

0141 245 7736

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUVSVRVNAKUAR
Date   Source Headline
25th Mar 20227:00 amRNSHalf-year Report
24th Mar 20223:02 pmRNSNet Asset Value(s)
24th Feb 20227:00 amRNSNet Asset Value(s)
25th Jan 20227:00 amRNSNet Asset Value(s)
11th Jan 20223:30 pmRNSHolding(s) in Company
10th Jan 20227:00 amRNSManagement Arrangements
29th Dec 20212:06 pmRNSSecond Price Monitoring Extn
29th Dec 20212:00 pmRNSPrice Monitoring Extension
24th Dec 202112:00 pmRNSNet Asset Value(s)
16th Dec 20213:30 pmRNSB Share Scheme
16th Dec 20213:15 pmRNSResult of AGM and GM
15th Dec 20215:30 pmRNSHolding(s) in Company
29th Nov 20217:00 amRNSNet Asset Value(s)
4th Nov 20211:03 pmRNSHolding(s) in Company
28th Oct 20219:00 amRNSNet Asset Value(s)
21st Oct 20212:00 pmRNSPortfolio Manager Update
21st Oct 20217:05 amRNSPublication of a circular
21st Oct 20217:00 amRNSAnnual Financial Report
5th Oct 202111:28 amRNSReview of Material Loan
25th Aug 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
20th Aug 20217:00 amRNSAmendment and Termination of IMA
11th Aug 20217:00 amRNSMonthly net asset value and fact sheet
12th Jul 20218:37 amRNSMonthly Net Asset Value and Fact Sheet
7th Jul 20217:00 amRNSB Share Scheme
5th Jul 20217:00 amRNSPortfolio Manager Update
25th Jun 20214:55 pmRNSPortfolio Manager Update
24th Jun 202112:04 pmRNSChange of Auditors
8th Jun 20215:02 pmRNSReview of Film Production Financing
1st Jun 20217:00 amRNSReview of Film Production Financing
26th May 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
11th May 20213:00 pmRNSPortfolio Manager Update
4th May 202112:16 pmRNSB Share Scheme
28th Apr 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
31st Mar 20217:00 amRNSCompletion of buyback of management shares
24th Mar 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
24th Mar 20217:00 amRNSHalf-year Report
23rd Mar 20214:05 pmRNSResult of Meeting
19th Mar 202112:30 pmRNSHolding(s) in Company
11th Mar 20217:00 amRNSAdditional information re publication of circular
26th Feb 202111:00 amRNSPublication of a circular
26th Feb 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
28th Jan 20217:00 amRNSMonthly Net Asset Value and Fact Sheet
31st Dec 20208:31 amRNSMonthly Net Asset Value and Fact Sheet
16th Dec 20206:13 pmRNSResult of AGM
26th Nov 20207:00 amRNSMonthly Net Asset Value, Dividend and Fact Sheet
29th Oct 20207:00 amRNSMonthly Net Asset Value and Fact Sheet
9th Oct 20207:00 amRNSAnnual Financial Report
28th Sep 20204:45 pmRNSMonthly Net Asset Value and Fact Sheet
28th Sep 20201:00 pmRNSDisclosure of Rights attaching to Shares
17th Sep 20204:15 pmRNSResult of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.